Romanian Authority Issues further GDP Non-Compliance Report
Last month, we reported that the Competent Authority of Romania (National Authority Of Medicines And Medical Devices, NAMMDR) has issued two GDP Non-Compliance Reports in the EudraGMDP database.
Now, another report has been published in mid-November, following an inspection conducted on 16 October 2024, at a wholesale distributor in Craiova, Romania. Based on the information gained during the inspection the company only supplied medicines to Romanian customers.
The authority identified several deficiencies:
- The Responsible Person (RP) failed to demonstrate sufficient knowledge of the Good Distribution Practice (GDP) Guide and other relevant legislative regulations governing the distribution of medicinal products for human use.
- Significant shortcomings were found in the organization and functioning of the company’s quality management system.
- The IT system was inadequate, unable to effectively support operational activities and meet the traceability and monitoring requirements mandated by current regulations.
As a result of these findings, the Wholesale Distribution Authorization (WDA) was suspended.
Source: EudraGMDP Database (Inspection Date: 16 October 2024; Report Number: 003-2024-NCD). *
* To find the respective report, please click on "Non-Compliance Reports" in the menu on the left-hand side and select in "From Date / To Date" the month the inspection took place. After clicking on "Search" the results list will be displayed, from which you can choose the report with the number mentioned above.
Related GMP News
17.12.2024GDP in the US: Pre-posting of USP Chapter <1079.2> on MKT
19.11.2024Swissmedic updates Guideline for Conducting Inspections
19.11.2024BioPhorum Article on Resilience of the Supply Chain
19.11.2024Romanian Authority Issues two new GDP Non-Compliance Reports
10.10.2024SwissGMDP Database now available